Patent 11608518 was granted and assigned to Cambridge Epigenetix Limited on March, 2023 by the United States Patent and Trademark Office.
Provided herein are methods, systems, and compositions for determining a base in a polynucleotide. In various aspects, the methods, systems, and compositions presented herein are useful for performing 4-base, 5-base, or 6-base sequencing of polynucleotide molecules, for example, from liquid biopsy samples or wherein the base is a low frequency mutation.